1H and 13C nuclear magnetic resonance studies of plasma from patients with primary intracranial neoplasms.
Plasma from patients with malignant and benign primary intracranial neoplasms and from healthy control subjects has been examined using proton (1H) and carbon-13 nuclear magnetic resonance (NMR) spectroscopy. Some features in the spectra of plasma from patients with malignant tumors differ significantly (p less than 0.01) from the corresponding features in the spectra of plasma from control subjects and from patients with benign tumors. The NMR spectral parameters vary consistently with the Kernohan grade of astrocytoma, which may suggest that they give a measure of tumor growth kinetics. The observed spectral differences are shown to be due to elevated levels of monounsaturated and polyunsaturated fatty acid residues in the plasma of cancer patients. It is proposed that these lipid residues arise from cell membranes shed from cells in growing tumors. The ability to follow tumor growth kinetics directly may be of considerable importance in elucidating the effects of primary intracranial neoplasm therapy.
Peeling
J
J
Department of Chemistry, University of Manitoba, Winnipeg, Canada.
Sutherland
G
G
Marat
K
K
Tomchuk
E
E
Bock
E
E
D000328:Adult; D000368:Aged; D000818:Animals; D001254:Astrocytoma / Q000097:blood / Q000473:pathology; D001932:Brain Neoplasms / Q000097:blood* / Q000473:pathology; D002247:Carbon Isotopes; D005227:Fatty Acids / Q000097:blood; D005909:Glioblastoma / Q000097:blood / Q000473:pathology; D006168:Guinea Pigs; D006801:Humans; D008055:Lipids / Q000097:blood; D009682:Magnetic Resonance Spectroscopy; D008875:Middle Aged; D011522:Protons
D002247:Carbon Isotopes; D005227:Fatty Acids; D008055:Lipids; D011522:Protons